Sökning: id:"swepub:oai:gup.ub.gu.se/182506" >
The safety of long-...
The safety of long-acting β2-agonists in the treatment of stable chronic obstructive pulmonary disease
-
Decramer, Marc L (författare)
-
Hanania, Nicola A (författare)
-
- Lötvall, Jan, 1956 (författare)
- Gothenburg University,Göteborgs universitet,Krefting Research Centre
-
visa fler...
-
Yawn, Barbara P (författare)
-
visa färre...
-
(creator_code:org_t)
- 2013
- 2013
- Engelska.
-
Ingår i: International journal of chronic obstructive pulmonary disease. - 1178-2005. ; 8, s. 53-64
- Relaterad länk:
-
https://gup.ub.gu.se...
-
visa fler...
-
https://doi.org/10.2...
-
visa färre...
Abstract
Ämnesord
Stäng
- Inhaled long-acting bronchodilators are the mainstay of pharmacotherapy for chronic obstructive pulmonary disease (COPD). Both the twice-daily long-acting β(2)-adrenoceptor agonists (LABAs) salmeterol and formoterol and the once-daily LABA indacaterol are indicated for use in COPD. This review examines current evidence for the safety of LABAs in COPD, focusing on their effect on exacerbations and deaths.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Lungmedicin och allergi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Respiratory Medicine and Allergy (hsv//eng)
Nyckelord
- Adrenergic beta-2 Receptor Agonists
- adverse effects
- Albuterol
- adverse effects
- analogs & derivatives
- Blood Glucose
- analysis
- Cough
- chemically induced
- Ethanolamines
- adverse effects
- Headache
- chemically induced
- Humans
- Indans
- adverse effects
- Nasopharyngitis
- chemically induced
- Potassium
- blood
- Pulmonary Disease
- Chronic Obstructive
- drug therapy
- Quinolones
- adverse effects
- Respiratory Tract Infections
- chemically induced
- Spasm
- chemically induced
- Tachycardia
- chemically induced
- Tremor
- chemically induced
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas